Measured by its ability to cleave the fluorogenic peptide substrate Boc-QAR-AMC (Catalog # ES014). The specific activity is >300 pmol/min/µg, as measured under the described conditions.
Source
Mouse myeloma cell line, NS0-derived human Spinesin protein Tyr71-Leu457 (Phe369Leu), with an N-terminal 9-His tag Accession # NP_110397
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain
Endotoxin Note
<1.0 EU per 1 μg of the protein by the LAL method.
Applications/Dilutions
Dilutions
Enzyme Activity
Theoretical MW
43 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
63 kDa, reducing conditions
Publications
Read Publication using 2495-SE in the following applications:
1,10 Phenanthroline (Sigma, Catalog # 320056), 0.6 M stock in DMSO
Substrate: BOC-Gln-Ala-Arg-AMC (Catalog # ES014), 10 mM stock in DMSO
F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
Dilute rhSpinesin to 200 µg/mL in Activation Buffer.
Dilute Thermolysin to 2 µg/mL in Activation Buffer.
Combine equal amounts of 200 µg/mL rhSpinesin and 2 µg/mL Thermolysin.
Incubate the reactions at 37 °C for 1 hour.
Stop the Thermolysin activity by adding 1,10 Phenanthroline to a final concentration of 10 mM.
Dilute activated rhSpinesin to 2 ng/µL in Assay Buffer.
Dilute Substrate to 200 µM in Assay Buffer.
Load 50 µL of 2 ng/µL rhSpinesin into a plate, and start the reaction by adding 50 µL of 200 µM Substrate.
Include a Substrate Blank containing 50 µL of Assay Buffer and 50 µL of Substrate.
Read at excitation and emission wavelengths of 380 nm and 460 nm (top read), respectively, in kinetic mode for 5 minutes.
Calculate specific activity:
Specific Activity (pmol/min/µg) =
Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU)
amount of enzyme (µg)
*Adjusted for Substrate Blank **Derived using calibration standard 7-Amino, 4-Methyl Coumarin (Sigma, Catalog # A-9891).
Per Well:
rhSpinesin: 0.100 µg
Thermolysin: 0.001 µg
Substrate: 100 µM
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Human Spinesin Protein, CF
EC 3.4.21
EC 3.4.21.-
EC 3.4.21.4
MGC141886
MGC148044
Spinesin
TMPRSS5
transmembrane protease serine 5
transmembrane protease, serine 5
Background
Spinesin, encoded by the TMPRSS5 gene, is a member of type II transmembrane serine proteases (TTSPs) (1). Human Spinesin contains the following structural domains: a short N-terminal cytoplasmic tail (amino acid residues 1-49), a transmembrane domain (residues 50-70), a stem region and a serine protease domain (residues 71-457) (2). The domain structure of Spinesin is common to other TTSPs, many of which have additional domains. The stem region of Spinesin contains a scavenger receptor-like domain. The ectodomain of human Spinesin (residues 71-457) was expressed and purified as a single chain pro-enzyme. The deduced amino acid sequence contains a Leu instead of a Phe residue at position 369; the former is identical to the mouse protein (3, 4). The pro-enzyme can be activated and the resulting enzyme activity can be measured as described in the Activity Assay Protocol.
Hooper, J.D. et al. (2001) J. Biol. Chem. 276:857.
Yamaguchi, Y. et al. (2002) J. Biol. Chem. 277:6806.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Recombinant Human Spinesin Protein, CF and receive a gift card or discount.